Dakota Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,788
Closed -$353K 668
2023
Q3
$353K Sell
3,788
-1,206
-24% -$136K 0.02% 465
2023
Q2
$642K Buy
4,994
+1,869
+60% +$226K 0.03% 339
2023
Q1
$363K Sell
3,125
-2,514
-45% -$281K 0.02% 426
2022
Q4
$639K Buy
5,639
+1,907
+51% +$209K 0.05% 306
2022
Q3
$301K Buy
+3,732
New +$316K 0.02% 425
2022
Q1
Sell
-8,148
Closed -$1.09M 464
2021
Q4
$1.09M Buy
+8,148
New +$1.17M 0.12% 152

Other funds holding DXCM

Dakota Wealth Management's DXCM Position: Q4 2023 in Review

Dakota Wealth Management sold out of DexCom (DXCM) in Q4 2023, closing a stake of 3,788 shares — an estimated $353K sold.

Dakota Wealth Management first reported a position in DXCM in Q4 2021 and held it in 6 quarters. The position peaked at $1.09M in Q4 2021. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Dakota Wealth Management reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • Dakota Wealth Management sold 3,788 DexCom shares in Q4 2023, an estimated $353K.
  • Dakota Wealth Management first reported a position in DexCom in Q4 2021 and held it in 6 quarters.
  • Dakota Wealth Management's DexCom position peaked at $1.09M in Q4 2021.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Dakota Wealth Management's 13F filing for Q4 2023, filed 30 Jan 2024.